By Ryan Davis ( April 3, 2013, 8:26 PM EDT) -- Suggesting it may be interested in reviewing the scope of the Hatch-Waxman Act's safe harbor for drug patents, the U.S. Supreme Court on Tuesday asked Amphastar Pharmaceuticals Inc. to respond to an appeal by Momenta Pharmaceuticals Inc. in a patent dispute between the companies....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.